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Abstract: Genotoxicity screening tests aim to evaluate if and to what extent a compound in contact
with the human body (e.g., a drug molecule, a compound from the environment) interacts with DNA.
The comet assay is a sensitive method used to predict the risk of DNA damage in individual cells,
as it quantifies the tape breaks, being the alkaline version (pH > 13) the most commonly used in the
laboratory. Epithelial cells serve as biomatrices in genotoxicity assessments. As ca. 80% of solid
cancers are of epithelial origin, the quantification of the DNA damage upon exposure of epithelial
cells to a drug or drug formulation becomes relevant. Comet assays run in epithelial cells also have
clinical applications in human biomonitoring, which assesses whether and to what extent is the
human body exposed to environmental genotoxic compounds and how such exposure changes over
time. Ocular mucosa is particularly exposed to environmental assaults. This review summarizes
the published data on the genotoxicity assessment in estimating DNA damage in epithelial cells
with a special focus on ocular cell lines. General comet assay procedures for ex vivo and in vivo
epithelium samples are also described.
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1. Introduction
The human eye is a sensitive organ with a unique and complex anatomy and physiology, posing
interesting challenges as a drug delivery route. The tear film and conjunctiva are the first obstacles that
need to be overcome for a drug to penetrate the eye. Its anatomic barriers (e.g., several layers of cornea,
sclera, and retina) together with the blood–aqueous (BAB) and blood–retinal (BRB) barriers, choroidal
and conjunctival blood flows also compromise the delivery of drugs into deeper tissues [1–3]. For the
treatment of eye diseases, topical administration of a drug formulation onto the ocular mucosa is
preferential over systemic administration, in which most cases require an injection that is less compliant
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and has a higher risk of infection. Before reaching the anatomical barrier of the cornea, any drug
administered onto the ocular surface will firstly overcome the precorneal barriers. Several advantages
can be highlighted in topical ocular drug delivery, namely: (i) it is needle-free, not requiring the
assistance of trained personnel for administration, which improves patient compliance compared to
other invasive routes; (ii) improved bioavailability of hydrophilic and low molecular weight drugs;
(iii) the large absorption surface area and high vascularization offers faster drug absorption and
earlier onset of action; (iv) effectiveness in emergency therapy; and (v) circumvents the hepatic
first-pass metabolism, requiring less drug compared to oral administration. However, the topical eye
administration also poses some disadvantages, such as: (i) the limited permeability of the cornea,
resulting in low drug absorption; (ii) part of the administered dose is drained into the tear duct, causing
undesired systemic side effects; and (iii) a frequent dosing regimen is usually needed because of the
short duration of the therapeutic effect due to the fast clearance of the drug from the eye because of
tear flow and blinking [4,5]. To overcome the identified limitations, drug delivery systems have been
used to improve the bioavailability of the drugs when administered topically onto the eye mucosa.
Screening for the risk of genotoxicity of these drug delivery systems in ocular cell lines is a first step in
the selection of the most promising systems.
Genotoxic agents have metabolic biological activity and are able to change information encoded in
deoxyribonucleic acid (DNA). This can occur when exposure to a toxic agent changes the structure or
content of chromosomes (clastogenicity) or the sequence of DNA base pairs (mutagenicity). Genotoxic
effects can appear in lower concentrations of substances and influence the reproduction, embryonic life,
development, growth, and survival of organisms. DNA changes are also associated with carcinogenesis
and hereditary defects (mutations, teratogenesis and genetic background pathologies) [6]. Genotoxicity
assays are used to screen mutations in DNA and chromosomal changes induced by a drug or
a formulation. As cancer may also be the result of genetic mutations, the ability of a compound to
cause damage to genes is sometimes not clear [7,8].
In vitro and in vivo genotoxicity assays are fast, economically accessible, efficient in determining
the ability of the new compound or new drug formulation to interact with DNA (and cause mutations,
chromosome damage or affect the ability to repair DNA), and can be used as an indicator of
carcinogenicity [9]. As these in vitro and in vivo assays are very simple, they can be useful in
the first genotoxicity screening a new drug formulation [10].
The eye lens accumulates new cell layers over the existing ones which means that a chronological
record of cells is kept over the course of life. The substance of the lens is composed of lens fibers;
the cytoplasm of these latter is highly enriched in proteins. Over time, these proteins undergo structural
changes either by natural aging or due to a systemic disease, some of which can lead to opacification.
Aging is a major risk factor for the onset of several chronic diseases, and any structural changes may
end up in the loss of capacities, including vision. Besides, DNA is particularly sensitive to reactive
oxygen species (ROS); these can be neutralized using nutraceuticals with antioxidant properties [11–25],
which protect DNA, promote its repair, and reduce the risk of age-related diseases. Single-cell gel
(SCG) electrophoresis is a sensitive genotoxicological test that evaluates DNA damage in individual
cells and enables the quantification of tape breaks [26–28]. In comparison to other techniques, such as
53BP1/γH2AX focus formation assays, the SCG electrophoresis assay shows the effect of genotoxic
agents on the physical status of genomic DNA and can readily detect eventual antioxidant effects on
DNA double-strand break formation [29]. This technique was developed by Östling and Johanson
when working with micro-gel DNA electrophoresis [30], and by Singh et al. who, through the use
of an alkaline solution, demonstrated its high sensitivity [31]. Over the years, this single-cell gel
electrophoresis technique has been extensively modified and validated, now commonly referred to as
the comet assay [32]. The advantages of the SCG test include its precision, reproducibility, simplicity,
and fast performance [26,33]. It is sensitive for DNA damage detection, it allows for data analysis of
individual cells, it requires only a very small amount of sample to be tested and is applicable to all
eukaryote cells. Any cell type with a nucleus can be tested and, besides that, this assay requires only
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a small number of cells. It allows for image analysis, thus facilitating the measurements, while the
costs are also extremely low. The comet assay is becoming a standard laboratory approach for the
screening of formulations’ risk in inducing DNA damage [26,34]. In this review, the concept behind
the comet assay and its implementation in ocular epithelial cells are discussed, summarizing published
data that focus on its use in the evaluation of DNA damage.
2. The Anatomy and Physiology of the Human Eye
The human eye is a complex structure that collects information about the surroundings.
The eye—an essential sensory organ—allows visualization through its ability to stimulate the nervous
system by refracting light, thus producing a focused image [4]. The ocular globe with its complex
anatomy is composed of different structures. The eyeball is so named because of its globe shape,
which is confined inside a bony cavity and protected by the eyelids. It is divided into three layers: (i) the
outermost layer, consisting of the cornea and the sclera; (ii) the anterior middle layer, consisting of the
iris, choroid and ciliary body; and (iii) the inner layer composed of the retina, which is an extension
of the central nervous system (CNS) [35]. Figure 1 describes the main anatomical and physiological
features of the eye structure.
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Figure 1. Anatomical and physiological features of the eye structure. 
Figure 1. Anatomical and physiological features of the eye structure.
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3. Comet Assay
Several ocular cell lines are available for the evaluation of the drug response and risk of DNA
damage. Table 1 summarizes their main features. The integrity of DNA is instrumental to health,
but the molecule is vulnerable to ROS, which induce its damage. The guidelines for the correct use of
the comet assay in genetic toxicology were launched at the International Workshop on Genotoxicity
Test Procedures (IWGTP) and concluded that the alkaline version (pH > 13) is the best version of
this assay for identifying genotoxic activity [31,36]. This comet assay can detect DNA single-strand
breaks (SSB), alkali labile sites (ALS), DNA-DNA/DNA-protein cross-linking, and SSB associated with
incomplete excision repair sites [36]. Figure 2 summarizes the endogenous and exogenous sources of
DNA damage and the different approaches used in the comet assay for its detection.
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Table 1. Ocular cell lines.
Ocular Cell Line Characteristics Refs
RPE-J RPE-J is a retinal pigment epithelial (RPE) cell line, obtained from the primary cultures of RPE cells obtained on 7-day-old Long–Evans rats. [37]
RF/6A RF/6A—monkey endothelial cell line—is spontaneously transformed at an early age and had been passaged over 540 times. [38]
BCE C/D 1-b BCE C/D-1b—cow endothelial cell line—is established from explants of normal adult bovine corneas. [39,40]
WERI-Rb-1 WERI-Rb-1 is a human retinoblastoma tumorigenic cell line used in cell differentiation and biomedical studies, and in animal models of tumor therapy. [41–43]
B-3 B-3 cell line was removed from a human lens obtained from a 5–12-month-old patient who was treated for premature retinopathy. This cell line was infected withAd12-SV40 at 60% confluence and passage 3. [44,45]
MP65 MP65 cell line-primary tumor of uveal melanoma of the eye in adults—is part of a panel that imitates the genetic alterations and mutations of this disease. [46]
2.040 pRSV-T 2.040 pRSV-T cell line is a primary culture of normal corneal epithelium, it is immortalized by transfection with the plasmid pRSV-T using lipofectamine.pRSV-T incorporates the SV40 early region genes and the Rous Sarcoma virus long terminal repeat. [47]
HCE-2 (50.B1) HCE-2 cell line is a primary culture of normal corneal epithelium, which by incubation was immortalized with the Ad12-SV40 hybrid virus. [47]
MP46 MP46 is a cell line from the primary tumor of uveal melanoma of the eye in adults with the same characteristics of the MP65 cell line. [46]
SIRC Statens Seruminstitut Rabbit Cornea is a cell line from the cornea of rabbits. The early appearance of distinct cytopathic changes makes it suitable for both thepropagation and quantification of the rubella virus, making this cell line appropriate for primary isolation of the rubella virus. [48]
Fugu Eye Fugu eye cell line was created from normal eye tissue. These cells maintain a compact genome size with small introns, that are telomerase positive. The cell line can beused for in vitro vertebrate genome research and for marine fish or aquaculture studies. [49]
ARPE-19 HPV-16
ARPE/HPV-16 transformed cell line was derived from the ARPE-19 cell line by transfection with DH5-HPV-16. ARPE-19 is a spontaneously arising retinal pigment
epithelium (RPE) cell line that derived from the normal eyes of a 19-year-old male who died from head trauma in a motor vehicle accident. The cells express the
RPE-specific markers CRALBP and RPE-65.
[50]
MP38
MP38 is a cell line from the primary tumor of uveal melanoma of the eye in adults. It belongs to a unique and first panel of 6 uveal melanoma cell lines from either
patient tumors or patient-derived tumor xenografts (PDXs). All these cell lines display GNAQ or GNA11 activating mutations. Four of them present BAP1 (BRCA1
associated protein-1) deficiency, which is known to be a characteristic of aggressive disease.
[46]
10.014 pRSV-T
10.014 pRSV-T cell line—an epithelial cell—was transfected with a plasmid that has the SV40 early region primary culture of normal corneal epithelium,
using lipofectamine to immortalize the transfection with plasmid pRSV-T. This plasmid has the SV40 early region genes as well as the Rous Sarcoma virus
long terminal repeat.
[51]
ARPE-19 ARPE-19 cell line—a transfection host—is a spontaneously arising retinal pigment epithelium (RPE). These cells form stable monolayers, exhibiting morphological andfunctional polarity. ARPE-19 expresses the RPE-specific markers CRALBP and RPE-65. These cells are diploid and can be carried for over 30 passages. [50,52]
MP41 MP41 is also a cell line from the primary tumor of uveal melanoma of the eye in adults and has the same characteristics as MP65, MP46 and MP38 cells lines. [46]
Y79
Y79 cell line was isolated after the enucleation of a primary tumor from the right eye, creating a culture. It is known that the donor had a family history of
retinoblastoma. After the development of this culture, it was possible to observe analogous ultrastructural characteristics as the original tumor (mainly nuclear
membrane infoldings, triple membrane structures, microtubules, large coated vesicles, basal bodies and centrioles, and annulate lamellae).
[43,53–56]
MM28 MM28 is also part of a panel of cell lines from the primary tumor of uveal melanoma from the adult eye, from either patient tumors or patient-derived tumorxenografts, also showing GNAQ or GNA11 activating mutations and BAP1 deficiency. [46]
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SCG electrophoresis or the comet assay allow the mapping of DNA damage in human cells in vivo,
not only from environmental and occupational exposure but also for therapeutic purposes. Due to its
versatility, this experimental test allows the exploration of the use of different cell types to assess DNA
damage (e.g., epithelial cells). As most solid cancers have an epithelial origin, it becomes relevant
to screen for the risk of DNA damage in these types of cells [36]. Epithelial cells are known to have
common structural features but have diverse functions due to many specialized adaptations [36,57–59].
The human biomonitoring comet assay studies using epithelial cells improved the protocols and
methodological conditions. It is not possible to generate a common protocol for all types of epithelial
cells. In this section, comet assay protocols using different ocular cell lines are described. A summary
of the comet assay protocols in epithelial cells are depicted in Table 2. Table 3 provides a description of
methods for isolation and separation of cells from different ocular tissues to be used in comet assays.
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3.1. Lens Epithelial Cells
Sorte et al. proposed the removal of the cells of the cornea and anterior chamber, maintaining
of the samples in minimum essential media, and a single rhexis placed in Eagle’s minimal essential
medium (DMEM) containing 10% fetal bovine serum (FBS) [60]. For sample preparation, the same
authors proposed the preparation of a cell suspension using mechanical stirring in 50 µL of PBS for
10–15 min at 4 °C to drop lens epithelial cells from the lens capsule. For the comet assay, the procedure
used by Singh et al. with modifications is then applied [31]. Cells in the second agarose layer are then
embedded by mixing equal volumes of the cell suspension with 2% low melting point agarose (LMPA).
For sampling and storage, Zhang et al. proposed the removal of the anterior chambers and placed
them in DMEM containing 15% FBS. Samples are collected within 30 min. The authors proposed the
suspending of single cells by sampling lens epithelium several times. After discarding the capsules,
the cell suspensions are centrifuged at 200 × g for 5 min at 4 °C, the supernatant is discarded, and the
cells are resuspended in PBS. To run the comet assay, the cell suspension is mixed with 0.75% LMPA
onto pre-coated slides with 0.75% normal melting point agarose (NMPA) [36,61].
Ringen et al. proposed the removal of the anterior chamber and the immediate placement of
the tissue samples in DMEM/F12 containing 15% FBS, following the sample analysis in the same
medium at 37 °C in the presence of 5% CO2 [62]. For the sample preparation for the comet assay,
the authors also proposed the suspending of single cells by sampling the lens epithelium several
times. After the discard of the capsule, the cell suspensions are also centrifuged at 200 × g for 5 min at
4 °C, the supernatant is discarded and the cells are resuspended in PBS. For the comet assay, the cell
suspension is mixed with 1% LMPA and some drops placed onto a dried glass slide pre-coated with
agarose. The authors also describe the enzymatic treatment using lesion-specific enzymes to detect
specific types of DNA damage [36].
3.2. Corneal Cells
Haug et al. stored the corneas in Optisol GS at 4 °C prior to transplantation, collecting the
remaining corneoscleral rims [63]. In this study, 10 rims were needed for the comet assay. For the
sample preparation, the authors carted off the epithelium by scraping on ice before gentle pipetting,
followed by centrifugation and resuspension of the cells in PBS. For the comet assay and enzymatic
treatment, lesion-specific enzymes were utilized for the detection of specific types of DNA damage [36].
Lorenzo et al. utilized human corneoscleral tissue (in this case obtained from rings after penetrating
keratoplasty). The corneolimbal rings were transferred to DMEM/F12 containing dishes, in which
the peripheral sclera and cornea were trimmed off. These rings were split into 12 samples which
were then washed in Hanks balanced salt solution (HBSS) in the absence of Ca2+ and Mg2+ at room
temperature. For sample preparation, the samples from each ring were incubated at 37 °C in a humid
atmosphere containing 5% CO2 in pre-equilibrated trypsin in HBSS containing EDTA-4Na in the
absence of Ca2+ and Mg2+. An equal amount of serum-containing growth medium (DMEM/F12) was
added to terminate enzyme activity by the end of the incubation period. Cells were gently dispersed
and the dissociated cells transferred from each well in media/enzymatic solution to tubes on ice [36,64].
To perform the comet assay and enzymatic treatment, the procedure developed by Azqueta et al. with
modifications was been applied [63–65].
3.3. Exfoliated Tear Duct Cells
In this type of comet assay, for the sampling protocol and sample storage, nasal brushing is carried
out to obtain the tears utilizing a capillary tube from the inner nasal angle of the eye, stimulating
the olfactory bulb. The samples are maintained in the capillary tubes at room temperature prior to
performing the comet procedure.
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Table 2. Summary of the comet assay protocols in epithelial cells.
Cell Type Previous Treatment Lysis Solution Electrophoresis Conditions NeutralizationSolution Staining Ref.
Corneal
(porcine)
Cells, suspended in 1% Type VII low gelling point
agarose, were transferred to a precoated slide
with 1% standard agarose
pH = 10
Triton X-100
2.5 M NaCl
0.1 M EDTA
10 mM Tris
Alkaline pH (not specified)
300 mM NaOH
1 mM EDTA
25 V/300 mA
20 min
pH = 7.5
0.5 M Tris
Ethidium
bromide [66]
Cornea
(human)
Cells, suspended in 0.65% low melting point
agarose, were transferred to a slide coated with
0.65% normal melting point agarose
pH = 10
2.5 M NaCl
100 mM EDTA
10 mM Tris
1% Triton X-100
10% DMSO
pH > 13
300 mM NaOH
1 mM EDTA
pH > 13
20 V/300 mA
20 min
pH = 7.5
0.4 M Tris
Ethidium
bromide [67]
Cornea and retina
(rat)
Cells, suspended in 0.5% low melting point
agarose, were transferred to a precoated slide
with 1% agarose (type I)
pH = 10
2.5 M NaCl
100 mM EDTA
10 mM Tris
1% N-laurylsarcosin
10% DMSO
1% Triton X-100
pH > 13
300 mM NaOH
1 mM EDTA
0.78 V/cm
40–60 min
pH = 7.5
0.4 M Tris
Propidium
iodide [68]
Cornea
(human)
Cells, suspended in 0.65% low melting point
agarose, were transferred to a slide coated with
0.65% normal melting point agarose
pH = 10
2.5 M NaCl
100 mM EDTA
10 mM Tris
1% Triton X-100
10% DMSO
pH>13
300 mM NaOH
1 mM EDTA
20 V/300 mA
20 min
pH = 7.5
0.4 M Tris
Ethidium
bromide [69]
Lens
(human)
Cells, suspended in 0.6% low melting point
agarose, were transferred to a slide coated with
normal melting point agarose
pH = 10
2.5 M NaCl
10 mM Tris
100 mM Na2 EDTA 1%
Triton X-100
Alkaline pH (not specified)
300 mM NaOH
1 mM EDTA
20 V
20 min
pH = 7.5
0.4 M Tris
Ethidium
bromide [70]
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Table 2. Cont.
Cell Type Previous Treatment Lysis Solution Electrophoresis Conditions NeutralizationSolution Staining Ref.
Lens
(human)
Cells, suspended in phosphate buffer saline and
1% low melting point agarose, were transferred to
a slide precoated with agarose (not specified)
pH = 10
2.5 M NaCl
10 mM Tris
100 mM EDTA
1% Triton X-100
pH = 13
300 mM NaOH
1 mM EDTA
1.4 V/cm / 300 mA
40-60 min
Phosphate
buffer saline
SYBR Gold [71]
Between lysis and electrophoresis, samples were
treated with three enzymes ((i) DNA glycosy-lase
(FPG); (ii) endonuclease III (endoIII); (iii) T4
endonuclease V (T4endoV))
Tear duct
Cells, suspended in 0.5% low melting point
agarose, were transferred to a slide precoated
with normal melting point agarose
pH = 10
2.5 M NaCl
10 mM Tris
100 mM Na2EDTA 1%
Triton X-100
10% DMSO
pH = 13
300 mM NaOH
1 mM EDTA
20 V/300 mA
20 min
pH = 7.5
0.4 M Tris
Ethidium
bromide [72]
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For sample preparation, the cells existing in the tear film that serves as a physiological solution do
not need special preparation, while the samples that are contained in the capillary tubes need to be
mixed with LMPA (0.5%). To perform the comet assay, the cell mixtures (tears and LMPA) are sampled
onto a normal precoated agarose slide and immediately covered with a cover-glass to form a microgel
to allow the agarose to jellify. A third LMP (0.5%) agarose layer is added, followed by the immersion
of the slides in a lysis solution (pH 10). It is still required to let DNA unwind in electrophoresis buffer
and to carry out electrophoresis at 0.8 V/cm [36,72].
Table 3. Some methods for isolation and separation of cells from different ocular tissues used for
further comet assay studies.
Cell Type Procedure Ref.
Corneal Epithelium
(porcine)
Trypsin treatment (0.25% trypsin/EDTA): dissected cornea was immersed in
trypsin/EDTA, incubated at 37 ◦C (5% CO2 atmosphere) and released cells from corneal
epithelium were collected after 30, 60 or 90 min, depending on the layer needed for
each assay. Cell membrane integrity was assessed with the trypan blue exclusion test.
[66]
Corneal(rabbit)
The eyes were enucleated and immersed in PBS. Cells were obtained after enzymatic
treatment with collagenase. The cornea was dissected in half, and the anterior section
was treated with collagenase to separate the stroma from epithelial cells. With this
process, the intact epithelium can be peeled off from the stroma. The epithelial piece
was washed with serum-free culture media, and after mincing, was treated with 0.25%
trypsin in calcium-free buffer solution.
[73]
Cornea and Retina
(Wistar rats)
Dissected tissues were immersed in HBSS buffer (4 ◦C). A cell suspension was
obtained by mincing cornea and retina tissues, in the same buffer, with a tweezer. [68]
Lens
(human)
Cell suspension of single cells was obtained by mechanical disruption. Lenses were
removed by an experienced surgeon after corneal incision and were kept in DMEM⁄F12
with 15% FBS and antibiotics at 4 ◦C. The lenses were then subjected to several rounds
of pipetting and the cells were easily obtained.
[71]
Tear Duct Cells were obtained from tears via collection with a capillary, which contains theexfoliated epithelial cells. [72]
Abbreviations: EDTA—ethylenediaminetetraacetic acid; PBS—phosphate buffer saline; HBSS—Hank’s balanced
salt solution; DMEM—Dulbecco’s modified eagle medium; FBS—fetal bovine serum.
Cerium oxide nanoparticles, known for their antioxidant properties, have been proposed for the
treatment of cataracts [70],—an eye condition associated with changes in the structural proteins of the
lens and intimately related to other age-related neurodegenerative diseases such as Alzheimer’s [74].
The risk of DNA damage has been evaluated on cultured human lens epithelial cells using the alkaline
comet assay. Cells were exposed to 5 and 10 µg/mL of nanoparticles, which did not show any DNA
damage or significant increases in the number of sister chromatid exchanges. The reported results
confirmed that cerium oxide nanoparticles do not compromise the eye lens and can be exploited in
non-surgical cataract treatments.
Guo et al. evaluated the risk of genotoxicity of zinc oxide nanoparticles in rat retinal ganglion cell
(RGC-5) lines [75]. The comet assay provided evidence that such nanoparticles are cytotoxic to RGC-5
cells. The integrity of the nuclei was compromised upon cell treatment with zinc oxide nanoparticles,
while untreated cells kept intact their nuclei. The extent of DNA damage was shown to be irreversible
and concentration-dependent (2.5, 5 and 10 µg/mL).
Coelho et at. developed therapeutic contact lenses from bacterial cellulose, coated with
an organic-inorganic hybrid compound containing aluminum alkoxide and glycidoxypropyl
trimethoxysilane, or chitosan nanoparticles to achieve full transparency of the material, which were
tested for their risk of genotoxicity using the comet assay in a Chinese hamster ovary (CHO-K1)
epithelial cell line [76]. The coating of lenses with organic–inorganic hybrid complex and chitosan
increased lens transparency and did not cause any genotoxicity effect; the genotoxicity reported in their
studies was attributed to the presence of sodium diclofenac—requiring further confirmation studies.
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4. Conclusions
Single-cell electrophoresis (“comet” assay) is currently being used as a standard approach for the
detection of DNA damage. In this microgel electrophoresis technique, cells are suspended in a thin
agarose gel on a microscope slide, are lysed, then electrophoresed and stained with a fluorescent dye
that binds to DNA. The cells that have been damaged in their DNA show an increased migration of
chromosomal DNA from the nucleus to the anode, resembling a comet. In the alkaline version (the
most used), DNA strands break and alkali-labile sites become visible, hence, the amount of migrated
DNA quantified is the amount of damaged DNA. Although not routinely used, the comet assay in
epithelial cells can be an important tool for risk assessment and also for the diagnosis and prognosis of
diseases. Due to the environmental exposure of the ocular mucosa, the use of its epithelial cells may
be a straightforward approach in the risk assessment of environmental and occupational exposure
besides therapeutic interventions, stimulating the use of the comet assay as a suitable human biomarker.
This comet assay has been employed in molecular epidemiology, mainly as a robust biomarker of the
early effects of diseases on human populations. The most noticeable advantage is its applicability in
almost any cell type, allowing exploration for the use of other biomatrices, including epithelial cells.
Epithelia are layers of cells that either line the walls of cavities or channels. Histological analyses have
shown that normal tissues containing epithelia are structurally similar. The fact that it is possible to
obtain epithelial cells by biopsies or less invasive procedures is an added-value in using such types of
cells to evaluate DNA damage safely and economically. As epithelia are in contact with exogenous and
endogenous damage sources, this makes them an interesting biomatrix for the individual genotoxicity
assessment of many compounds. Besides, the methodology can be used for diagnostic purposes
in clinical settings, offering a potential use in patients over time. The studies of lens and corneal
epithelial cells present clinical applications, mainly as biomarkers for genotoxicity assessments in
human monitoring. Some studies have shown that the lens cells are instrumental for DNA damage
detection in individuals with cataracts. This pathology is due to the oxidative stress and UV radiation
exposure. The comet assay in ocular cell lines can be used to understand eye pathologies (e.g., macular
degeneration). Corneal cells have been used to evaluate DNA damage in cells with the potential to
be transplanted, but it is necessary to take into account that additional damage can be induced by
the manipulation. Although not commonly used for genotoxicity evaluation, epithelial cells may be
an important matrix as the majority of human tumors come from epithelial tissues and the detection of
DNA damage can be performed simply by the use of the comet assay.
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